Support our online development, and advance our onground research initiatives in free market economics, as we seek to showcase the brightest Next-Gen minds.
THE ME-P DISCLAIMER: Posts, comments and opinions do not necessarily represent iMBA, Inc., but become our property after submission. Copyright © 2006 to-date. iMBA, Inc allows colleges, universities, medical and financial professionals and related clinics, hospitals and non-profit healthcare organizations to distribute our proprietary essays, photos, videos, audios and other documents; etc. However, please review copyright and usage information for each individual asset before submission to us, and/or placement on your publication or web site. Attestation references, citations and/or back-links are required. All other assets are property of the individual copyright holder.
MEDICAL EXECUTIVE-POST – TODAY’S NEWSLETTER BRIEFING
***
Essays, Opinions and Curated News in Health Economics, Investing, Business, Management and Financial Planning for Physician Entrepreneurs and their Savvy Advisors and Consultants
“Serving Almost One Million Doctors, Financial Advisors and Medical Management Consultants Daily“
A Partner of the Institute of Medical Business Advisors , Inc.
http://www.MedicalBusinessAdvisors.com
SPONSORED BY: Marcinko & Associates, Inc.
***
http://www.MarcinkoAssociates.com
| Daily Update Provided By Staff Reporters Since 2007. How May We Serve You? |
| © Copyright Institute of Medical Business Advisors, Inc. All rights reserved. 2025 |
REFER A COLLEAGUE: MarcinkoAdvisors@outlook.com
SPONSORSHIPS AVAILABLE: https://medicalexecutivepost.com/sponsors/
ADVERTISE ON THE ME-P: https://tinyurl.com/ytb5955z
Your Referral Count -0-
***
CITE: https://www.r2library.com/Resource
When it comes to scientific achievements that have advanced the practice of medicine, you’d be hard-pressed to find one more influential than the Human Genome Project. The project, a federally funded collaboration between scientists around the globe, began in October 1990 with the goal of improving our knowledge of human biology by sequencing an entire human genome, which is the complete set of DNA in a cell. Nearly 13 years and $2.7 billion later, the project wrapped up in April 2003, and scientists around the world now use the reference human genome to study genetics, biology, and more. Today, the entire human genome can be sequenced in as little as five hours and costs as little as $600. Learn more about the Human Genome Project’s impact here.
CITE: https://tinyurl.com/2h47urt5
🟢 What’s up
- Jack in the Box popped like a…well, you know…after activist investor Biglari Capital reportedly accrued a 10% stake in the fast-food company. Shares rose 7.86%.
- Robinhood Markets climbed 6.12% on speculation that it may be added to the S&P 500 to fill the spot left by Juniper Networks.
- Rigetti Computing rose 15.45% after Cantor Fitzgerald analysts initiated their coverage of the quantum computing company with an “overweight” rating.
- Verint Systems jumped 15.33% on reports that the customer service software maker may be acquired by Thoma Bravo.
- Corona parent company Constellation Brands gained 4.48% after it reiterated its fiscal guidance, assuring shareholders that aluminum tariffs will only cost the company about $20 million.
- Crypto companies gained across the board after bitcoin miner BitMine Immersion Technologies announced it’s pivoting to ethereum. BitMine rose 21.17%, MARA Holdings gained 13.38%, and CleanSpark climbed 12.64%.
What’s down
- Centene plunged 40.37% after the health insurer rescinded its fiscal 2025 guidance, warning that EPS will come in lower than anticipated.
- Centene’s news pulled the rest of the health insurance industry down with it. UnitedHealth Group lost 5.70%, CVS Health fell 4.28%, Elevance Health stumbled 11.50%, and Molina Healthcare dropped 21.97%.
- Paramount Global sank 2.43% after the company settled its 60 Minutes lawsuit with President Trump for $16 million.
- Marvell Technology slipped 2.61% on reports that Microsoft is cutting back on manufacturing AI chips in-house.
- Intel lost 4.25% on the news that it may be shifting the strategy behind its foundry business.
CITE: https://tinyurl.com/tj8smmes
Visualize: How private equity tangled banks in a web of debt, from the Financial Times.
COMMENTS APPRECIATED
PLEASE SUBSCRIBE: MarcinkoAdvisors@outlook.com
Thank You
***
***
***
***
EDUCATIONAL TEXTBOOKS: https://tinyurl.com/4zdxuuwf
***
Share this:
Filed under: Drugs and Pharma, Ethics, Information Technology, Investing, Marcinko Associates, Recommended Books, Sponsors | Tagged: Crick, DJIA, DNA, DOW, genome, human genome project, Investing, Marcinko, NASDAQ, PBMs, RNA, S&P 500, Technology, textbooks, VIX, watson | Leave a comment »
The Leading Business Education Network for Doctors, Financial Advisors and Health Industry Consultants 